Unknown

Dataset Information

0

Thrombolytic therapy for pulmonary embolism.


ABSTRACT:

SUBMITTER: Hao Q 

PROVIDER: S-EPMC6516871 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Thrombolytic therapy for pulmonary embolism.

Hao Qiukui Q   Dong Bi Rong BR   Yue Jirong J   Wu Taixiang T   Liu Guan J GJ  

The Cochrane database of systematic reviews 20181218


<h4>Background</h4>Thrombolytic therapy is usually reserved for patients with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still concerns about the possible risk of adverse effects of thrombolytic therapy, such as major or minor haemorrhage. This is the third update of the Cochrane review first published in 2006.<h4>Objective  ...[more]

Similar Datasets

| S-EPMC10315937 | biostudies-literature
| S-EPMC3861324 | biostudies-literature
| S-EPMC11565361 | biostudies-literature
| S-EPMC3219285 | biostudies-literature
| S-EPMC7997002 | biostudies-literature
| S-EPMC3905250 | biostudies-other
| S-EPMC9666748 | biostudies-literature
| S-EPMC3335447 | biostudies-literature
| S-EPMC7314323 | biostudies-literature
| S-EPMC10015747 | biostudies-literature